Clinical Trial Update: Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects [Phase 2]

View source ↗

Summary

This completed Phase 2 pharmacodynamic study evaluated a single dose of AZD2516 in healthy male subjects, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• AZD2516

Snippet

Sponsor: AstraZeneca | Conditions: Reflux | Phase 2 | Status: COMPLETED | Results posted: 2012-08-13